ILC1s and NK cells express inhibitory receptors, such as natural killer group 2 member A (NKG2A), Killer cell lectin-like receptor G1 (KLRG1), and other inhibitory receptors, which contribute to tumor advancement in an immunosuppressive TME [7,118]. Here, KLRG1 is linked to neoplasm.